AR028424A1 - Metodo para regular la angiogenesis utilizando proteina ryk - Google Patents

Metodo para regular la angiogenesis utilizando proteina ryk

Info

Publication number
AR028424A1
AR028424A1 ARP010102149A ARP010102149A AR028424A1 AR 028424 A1 AR028424 A1 AR 028424A1 AR P010102149 A ARP010102149 A AR P010102149A AR P010102149 A ARP010102149 A AR P010102149A AR 028424 A1 AR028424 A1 AR 028424A1
Authority
AR
Argentina
Prior art keywords
regulating angiogenesis
ryk protein
ryk
protein
angiogenesis
Prior art date
Application number
ARP010102149A
Other languages
English (en)
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of AR028424A1 publication Critical patent/AR028424A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP010102149A 2000-05-10 2001-05-07 Metodo para regular la angiogenesis utilizando proteina ryk AR028424A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56878300A 2000-05-10 2000-05-10

Publications (1)

Publication Number Publication Date
AR028424A1 true AR028424A1 (es) 2003-05-07

Family

ID=24272718

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102149A AR028424A1 (es) 2000-05-10 2001-05-07 Metodo para regular la angiogenesis utilizando proteina ryk

Country Status (13)

Country Link
EP (1) EP1287121A2 (es)
JP (1) JP2004527206A (es)
AR (1) AR028424A1 (es)
AU (1) AU2001261343A1 (es)
CA (1) CA2408349A1 (es)
CO (1) CO5300464A1 (es)
DO (1) DOP2001000164A (es)
EC (1) ECSP014068A (es)
GT (1) GT200100079A (es)
PE (1) PE20011218A1 (es)
SV (1) SV2002000442A (es)
UY (1) UY26696A1 (es)
WO (1) WO2001085789A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003206854A1 (en) * 2002-02-06 2003-09-02 Developgen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Kinases involved in the regulation of energy homeostasis
JO3283B1 (ar) 2011-04-26 2018-09-16 Sanofi Sa تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
TR201909951T4 (tr) 2014-07-18 2019-07-22 Sanofi Sa Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2135471A1 (en) * 1992-05-11 1993-11-25 Steven A. Stacker Receptor-type tyrosine kinase-like molecules
AU4606196A (en) * 1994-12-23 1996-07-19 Ludwig Institute For Cancer Research Assay, receptor proteins and ligands
AU4278299A (en) * 1998-06-11 1999-12-30 Astrazeneca Ab Human receptor tyrosine kinase
ES2316194T3 (es) * 1998-10-28 2009-04-01 Cornell Research Foundation, Inc. Metodos para la regulacion de la angiogenesis y la integridad vascular utilizando los ligandos bdnf, nt-3 y nt-4.

Also Published As

Publication number Publication date
DOP2001000164A (es) 2002-05-15
WO2001085789A2 (en) 2001-11-15
CA2408349A1 (en) 2001-11-15
WO2001085789A3 (en) 2002-05-16
ECSP014068A (es) 2002-02-25
SV2002000442A (es) 2002-07-03
JP2004527206A (ja) 2004-09-09
UY26696A1 (es) 2001-12-28
EP1287121A2 (en) 2003-03-05
AU2001261343A1 (en) 2001-11-20
PE20011218A1 (es) 2002-02-01
CO5300464A1 (es) 2003-07-31
GT200100079A (es) 2001-12-31

Similar Documents

Publication Publication Date Title
NO20025056L (no) System for innholdsfrembringelse/innholdservervelse
AR027976A1 (es) Anticuerpos humanos para cd154
FR2775183B1 (fr) Prothese inter-epineuse
ID23983A (id) Inhibitor-inhibitor aminotiazol untuk kinase-kinase tergantung siklin
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
DE60125853D1 (de) Bildherstellungsverfahren
DE60133721D1 (de) Bandbreitensteuertechnik für einen laser
ATE269324T1 (de) Hydroxyphenyl-piperidin-4-ylidene-methyl- benzamidderivate zur schmerzbekämpfung
DE60103427D1 (de) Übereinstimmungssteuerverfahren
PT988861E (pt) Formulacoes de proteina estabilizadas
AR028261A1 (es) Inhibidores triciclicos de la proteina quinasa
DE60139754D1 (de) Güterücksendeverfahren
AR028002A1 (es) Metodos para la produccion de ansamitocina
NO20001294D0 (no) Måler for skyvekraft
AR028201A1 (es) Metodo para aliviar la ansiedad
DE60141570D1 (de) Bildeditierverfahren
ATE289603T1 (de) Chinolinyl-piperidin-4-yliden-methyl-benzamid- derivate zur schmerzbekämpfung
PT1167260E (pt) Derivados de vitamina d3
DE60113610D1 (de) Wischersteuervorrichtung
DE60113612D1 (de) Wischersteuervorrichtung
AR028424A1 (es) Metodo para regular la angiogenesis utilizando proteina ryk
FI20002262A (fi) Menetelmä proteiinin rakenteen muuttamiseksi
AR028550A1 (es) Procedimiento para la obtencion de caprolactama
PT1171470E (pt) Anticorpos para a proteina placentaria 13
DE50107729D1 (de) Regelverfahren

Legal Events

Date Code Title Description
FA Abandonment or withdrawal